| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/30/2003 | EP1330515A1 Methods of agonizing and antagonizing fabk |
| 07/30/2003 | EP1330475A2 Neuromedin u delta polypeptides |
| 07/30/2003 | EP1330474A1 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 07/30/2003 | EP1330473A2 Streptococcal genes |
| 07/30/2003 | EP1330472A2 Cell cycle progression proteins |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330466A1 24 human secreted proteins |
| 07/30/2003 | EP1330447A2 Peptides as met-ap2 inhibitors |
| 07/30/2003 | EP1330265A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 07/30/2003 | EP1330260A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 07/30/2003 | EP1330259A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 07/30/2003 | EP1330252A1 In vivo stimulation of angiogenic activity |
| 07/30/2003 | EP1330156A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 07/30/2003 | EP1207751A4 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 07/30/2003 | EP1165121B1 SUPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 07/30/2003 | EP1158849A4 Plant ligand-gated ion channels |
| 07/30/2003 | EP1157037B1 Gcsf conjugates |
| 07/30/2003 | EP1130960A4 Transgenic animals |
| 07/30/2003 | EP1105525A4 A process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 07/30/2003 | EP1080112B1 Method for separating and/or isolating plasma proteins by annularchromatography |
| 07/30/2003 | EP1068530A4 Diagnostic for metastatic prostate cancer |
| 07/30/2003 | EP1056765A4 Human potassium channel genes |
| 07/30/2003 | EP1039873A4 Keratin-based hydrogel for biomedical applications and method of production |
| 07/30/2003 | EP0971580B1 Regulatory element for expressing genes in plants |
| 07/30/2003 | EP0956292A4 Conantokins |
| 07/30/2003 | EP0943097B1 METHOD TO DETECT IgE |
| 07/30/2003 | EP0910400B1 Therapies for chronic renal failure |
| 07/30/2003 | EP0851926B1 Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | EP0831936B1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 07/30/2003 | EP0831884B1 Use of bone morphogenic proteins for healing and repair of connective tissue attachment |
| 07/30/2003 | EP0785793B1 Allosteric modulators of the nmda receptor |
| 07/30/2003 | EP0730652B1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter |
| 07/30/2003 | EP0702696B1 Trifunctional antithrombin and antiplatelet peptides |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433471A 85Kgda neisserial antigen |
| 07/30/2003 | CN1433470A Neisserial antigenic peptides |
| 07/30/2003 | CN1433431A Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/30/2003 | CN1433429A Oligopeptides |
| 07/30/2003 | CN1433428A Immunological methodology for discerning human papillomavirus |
| 07/30/2003 | CN1433325A Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 07/30/2003 | CN1433324A Interferon gamma conjugates |
| 07/30/2003 | CN1433321A Vaccine for prevention and treatment of Alzhermer's and amyloid related diseases |
| 07/30/2003 | CN1432652A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432651A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432650A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432649A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1116305C Peptide derivatives |
| 07/30/2003 | CN1116303C Simple separating and purifying technique for phytohemagglutinin and its crystal growth |
| 07/29/2003 | US6600090 Genetically engineered plant for use in the generation and propagation of disease and pest resistant plant |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600024 Polypeptide for use in the treatment and prevention of cell proliferative disorders |
| 07/29/2003 | US6600023 Antibody directed against HIV-1 P25 antigen |
| 07/29/2003 | US6600022 Monoclonal antibody for use in treatment and preventon of autoimmune and allergic disease |
| 07/29/2003 | US6600021 Enzyme inhibitor for use in the preparation of dough and baked goods |
| 07/29/2003 | US6600020 Protein for use in the treatment of tumor and skin disorders in mammals; protein for use in veterinary medicine |
| 07/29/2003 | US6600019 Polypeptides and nucleic acids encoding same |
| 07/29/2003 | US6600018 Polypeptide for use in the treatment of tumors |
| 07/29/2003 | US6600017 Peptide for use in diagnosing alzheimer's disease |
| 07/29/2003 | US6600015 Treatment or prevention of obesity. |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6599881 Treating a thrombotic disorder that is not the result of an endotoxin-initiated coagulation cascade in a subject comprising administration of a bactericidal/ permeability-increasing protein (BPI) protein |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599876 Medicament and method for treating renal disease |
| 07/29/2003 | US6599875 IL-6 antagonist peptides |
| 07/29/2003 | US6599874 Isolated from human milk for prophylactic and/or therapeutic treatment of infections caused by bacteria, in particular Streptococcus pneumoniae and Haemophilus influenzae in upper and lower airways, ear-nose-and-throat infections |
| 07/29/2003 | US6599873 Proteins are co-mitogens (with phytohemaglutinin) for T-cells, cause both fibroblasts and chondrocytes to secrete latent collagenase, and increase the surface adhesive powers of endothelial cells for neutrophils |
| 07/29/2003 | US6599752 Process for separating and analyzing hydrophobic proteins using thin layer chromatography |
| 07/29/2003 | US6599745 Method to isolate mutants and to clone the complementing gene |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599738 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 07/29/2003 | US6599737 Adenoviral vectors with tandem fiber proteins |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599718 Growth hormone secretagogue related receptors and nucleic acids |
| 07/29/2003 | US6599717 Polypeptide for use in the treatment tumors, diabetic retinopathy and rheumatoid arthritis |
| 07/29/2003 | US6599716 Nucleic acids encoding NTR3, a member of the TNF-receptor supergene family |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599510 Abundant extracellular products and methods for their production and use |
| 07/29/2003 | US6599509 Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2179014C Method for inducing dna synthesis in neurons |
| 07/29/2003 | CA2146965C Cyclin complex rearrangement and uses related thereto |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2122044C Hiv immunotherapeutics |
| 07/29/2003 | CA2117599C Method for modulating proopiomelanocortin synthesis in a mammal |